According to Oneness Biotech's website, FESPIXON, its DFU new drug has been informed the approval by Singapore Health Science Authority (HSA).

In 2021, the company received its DFU drug approval in Taiwan and later a relevant approval in Macao. It plans to expand into Malaysia and Thailand, subsequently into Indonesia, India, Vietnam and the Philippines. 

More details on the drug development please visit www.onenessbio.com